News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
722,144 Results
Type
Article (64520)
Company Profile (215)
Press Release (657409)
Section
Business (205177)
Career Advice (3386)
Deals (35780)
Drug Delivery (113)
Drug Development (83843)
Employer Resources (185)
FDA (17446)
Job Trends (16100)
News (354794)
Policy (36649)
Tag
Academia (2913)
Alliances (52782)
Alzheimer's disease (1318)
Approvals (17350)
Artificial intelligence (145)
Bankruptcy (363)
Best Places to Work (12032)
Biotechnology (142)
Breast cancer (123)
Cancer (1101)
Cardiovascular disease (97)
Career advice (2864)
Cell therapy (251)
Clinical research (66197)
Collaboration (381)
Compensation (131)
COVID-19 (2766)
C-suite (96)
Data (1061)
Diabetes (164)
Diagnostics (6489)
Drug pricing (101)
Earnings (79703)
Employer resources (161)
Events (103228)
Executive appointments (292)
FDA (17967)
Funding (348)
Gene therapy (190)
GLP-1 (672)
Government (4861)
Healthcare (19635)
Infectious disease (2857)
Inflammatory bowel disease (117)
Interviews (653)
IPO (16103)
Job creations (4422)
Job search strategy (2373)
Layoffs (480)
Legal (9223)
Lung cancer (182)
Manufacturing (192)
Medical device (13553)
Medtech (13558)
Mergers & acquisitions (19720)
Metabolic disorders (448)
Neuroscience (1600)
NextGen Class of 2024 (7113)
Non-profit (4980)
Northern California (1372)
Obesity (258)
Opinion (240)
Patents (104)
People (57341)
Phase I (20267)
Phase II (28871)
Phase III (22158)
Pipeline (451)
Postmarket research (2911)
Preclinical (8817)
Radiopharmaceuticals (240)
Rare diseases (226)
Real estate (6514)
Regulatory (23944)
Research institute (2607)
Resumes & cover letters (527)
Southern California (1217)
Startups (3823)
United States (12811)
Vaccines (637)
Weight loss (210)
Date
Last 7 days (914)
Last 30 days (3447)
Last 365 days (35895)
2024 (32505)
2023 (40297)
2022 (51389)
2021 (56015)
2020 (55322)
2019 (49222)
2018 (37488)
2017 (34937)
2016 (34627)
2015 (39812)
2014 (33839)
2013 (30171)
2012 (30838)
2011 (31115)
2010 (29549)
Location
Africa (1062)
Arizona (162)
Asia (43969)
Australia (7501)
California (3073)
Canada (1241)
China (248)
Colorado (147)
Connecticut (145)
Europe (98949)
Florida (446)
Georgia (117)
Illinois (365)
Indiana (194)
Kansas (96)
Maryland (563)
Massachusetts (2369)
Michigan (168)
Minnesota (250)
New Jersey (928)
New York (907)
North Carolina (741)
Northern California (1372)
Ohio (137)
Pennsylvania (782)
South America (1443)
Southern California (1217)
Texas (428)
Washington State (347)
722,144 Results for "la jolla institute for allergy and immunology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
La Jolla Institute for Immunology and RevolKa started a Research Collaboration
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology agreed to start a research collaboration to create antigens for the next-generation vaccines to deliver innovative solutions to unmet medical need in infectious diseases.
April 18, 2024
·
2 min read
Press Releases
Dr. Naba Sharif Elected President of the New Jersey Allergy Asthma and Immunology Society
November 8, 2024
·
5 min read
Biotech Beach
Cover the Latest Developments in Allergy and Clinical Immunology at the EAACI Congress 2024 in Valencia, Spain
The European Academy of Allergy and Clinical Immunology, with a membership of over 16,000 from 125 countries, annually orchestrates its congress to unveil the latest research and innovative advancements in allergy and clinical immunology.
March 19, 2024
·
2 min read
Press Releases
KalVista Pharmaceuticals Presents New Sebetralstat Data at the 2024 American College of Allergy Asthma and Immunology
October 28, 2024
·
7 min read
Genetown
Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress
Astria Therapeutics, Inc. today announced that it will present two posters at the upcoming European Academy of Allergy and Clinical Immunology (EAACI) Congress in Valencia, Spain on June 1, 2024.
May 23, 2024
·
1 min read
Press Releases
Astria Therapeutics to Present at Upcoming Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting
October 30, 2024
·
1 min read
Pharm Country
Intrommune Therapeutics To Present A New Form Of Allergy Treatment At The 2024 American Academy Of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
Intrommune Therapeutics, Inc. today announced data from The First Study To Evaluate Oral Mucosal Immunotherapy (OMIT) For The Treatment Of Food Allergy has been selected as a Late Breaking Poster Presentation at the 2024 American Academy of Allergy, Asthma & Immunology in Washington, DC.
February 6, 2024
·
3 min read
News
Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting
October 21, 2024
·
1 min read
Bio NC
BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology
BioCryst Pharmaceuticals Inc. announced that new data on oral, once-daily ORLADEYO® for the prophylactic treatment of hereditary angioedema will be presented at the European Academy of Allergy and Clinical Immunology meeting in Valencia, Spain from May 31 to June 3, 2024.
May 14, 2024
·
5 min read
Business
La Jolla Institute for Immunology Acquires the Carterra LSA Platform to Advance State-of-the-Art Immunological and Infectious Disease Research
Carterra, Inc. and La Jolla Institute for Immunology (LJI) announced today that LJI has acquired a Carterra LSA instrument to enhance its antibody screening and characterization work.
August 1, 2022
·
5 min read
1 of 72,215
Next
